Speaking of compounders, I've learned a lot about compounded medications recently
Johansen NJ, Dejgaard TF, Lund A et al (2020) Efficacy and safety of meal-time administration of short-acting exenatide for glycaemic control in type 1 diabetes (MAG1C): a randomised, double-blind, placebo-controlled trial
LKB1, a tumor suppressor, is a major mammalian AMPK kinase in the liver that activates AMPK by phosphorylating the Thr172 residues of AMPK subunits
The ideal candidates should have underlying conditions like high blood pressure, cardiovascular issues, or sleep apnea
Each vial contains an 80mg total blend composed of 50mg GHK-Cu, 10mg TB-500, 10mg BPC-157, and 10mg KPV
Traditional sublingual drops often slide off the tissue quickly, resulting in the medication being swallowed rather than absorbed through the mucous membranes